IBM shares rose 2.98% to $298.54 on February 6, recovering some losses triggered by concerns that Anthropic's Claude Cowork plugins could automate enterprise software workflows, which traditionally provide premium revenue for IBM.
- Wall Street maintains a "Moderate Buy" consensus, with price targets reaching $380, implying a potential 30% upside.
- Management guided for 5%+ revenue growth in 2026 following strong Q4 results that showed double-digit Software and Infrastructure growth.
- Generative AI bookings exceeded $12.5 billion, and the stock currently trades at 25x forward earnings, a discount to comparable SaaS companies.